Atelerix is a biotechnology company providing an innovative solution for storing and transporting cells and tissues at room temperature. As the company approached its 3rd birthday it was planning to expand its team, just as the country went into lockdown. We spoke to Mick McLean, CEO of Atelerix, Clive Stanway, Non-Executive Director of Atelerix, and […]
read moreTim Bestwick shares his insights on the opportunities and challenges for startups in the fusion energy industry of the future The UK is a driving force in fusion energy and hosts the world’s leading fusion machine, the EU’s Joint European Torus (JET). The UK government has recently announced an investment of £220m for the initial […]
read moreIn a recent article for OBN’s CONNECT magazine, UKI2S provides its insights into early stage investment for life science companies and the key things investors are looking for. Seed stage funding is a crucial step for early stage life sciences companies in achieving long term success. It can provide essential support to overcome the challenges […]
read more